ImageneBio Stock Forward View - Polynomial Regression
| IMA Stock | 7.51 0.18 2.46% |
ImageneBio Stock outlook is based on your current time horizon. Investors can use this forecasting interface to forecast ImageneBio stock prices and determine the direction of ImageneBio's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of ImageneBio's historical fundamentals, such as revenue growth or operating cash flow patterns.
At this time, The RSI of ImageneBio's share price is at 54. This usually indicates that the stock is in nutural position, most likellhy at or near its resistance level. The main idea of RSI analysis is to track how fast people are buying or selling ImageneBio, making its price go up or down. Momentum 54
Impartial
Oversold | Overbought |
EPS Estimate Current Year (0.99) | EPS Estimate Next Year (3.32) | Wall Street Target Price 30 |
Using ImageneBio hype-based prediction, you can estimate the value of ImageneBio from the perspective of ImageneBio response to recently generated media hype and the effects of current headlines on its competitors.
The Polynomial Regression forecasted value of ImageneBio on the next trading day is expected to be 7.72 with a mean absolute deviation of 0.22 and the sum of the absolute errors of 13.53. ImageneBio after-hype prediction price | USD 7.59 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
ImageneBio | Build AI portfolio with ImageneBio Stock |
ImageneBio Additional Predictive Modules
Most predictive techniques to examine ImageneBio price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for ImageneBio using various technical indicators. When you analyze ImageneBio charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
ImageneBio Polynomial Regression Price Forecast For the 1st of February
Given 90 days horizon, the Polynomial Regression forecasted value of ImageneBio on the next trading day is expected to be 7.72 with a mean absolute deviation of 0.22, mean absolute percentage error of 0.08, and the sum of the absolute errors of 13.53.Please note that although there have been many attempts to predict ImageneBio Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that ImageneBio's next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
ImageneBio Stock Forecast Pattern
| Backtest ImageneBio | ImageneBio Price Prediction | Buy or Sell Advice |
ImageneBio Forecasted Value
In the context of forecasting ImageneBio's Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. ImageneBio's downside and upside margins for the forecasting period are 3.97 and 11.48, respectively. We have considered ImageneBio's daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Polynomial Regression forecasting method's relative quality and the estimations of the prediction error of ImageneBio stock data series using in forecasting. Note that when a statistical model is used to represent ImageneBio stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 117.472 |
| Bias | Arithmetic mean of the errors | None |
| MAD | Mean absolute deviation | 0.2182 |
| MAPE | Mean absolute percentage error | 0.0313 |
| SAE | Sum of the absolute errors | 13.5277 |
Predictive Modules for ImageneBio
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as ImageneBio. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.ImageneBio After-Hype Price Density Analysis
As far as predicting the price of ImageneBio at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in ImageneBio or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of ImageneBio, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
ImageneBio Estimiated After-Hype Price Volatility
In the context of predicting ImageneBio's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on ImageneBio's historical news coverage. ImageneBio's after-hype downside and upside margins for the prediction period are 3.84 and 11.34, respectively. We have considered ImageneBio's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
ImageneBio is slightly risky at this time. Analysis and calculation of next after-hype price of ImageneBio is based on 3 months time horizon.
ImageneBio Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as ImageneBio is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading ImageneBio backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with ImageneBio, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.12 | 3.75 | 0.08 | 0.04 | 7 Events / Month | 7 Events / Month | In about 7 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
7.51 | 7.59 | 1.07 |
|
ImageneBio Hype Timeline
On the 31st of January ImageneBio is traded for 7.51. The entity has historical hype elasticity of 0.08, and average elasticity to hype of competition of 0.04. ImageneBio is expected to increase in value after the next headline, with the price projected to jump to 7.59 or above. The average volatility of media hype impact on the company the price is over 100%. The price jump on the next news is projected to be 1.07%, whereas the daily expected return is currently at -0.12%. The volatility of related hype on ImageneBio is about 1041.67%, with the expected price after the next announcement by competition of 7.55. The company reported the last year's revenue of 3.5 M. Reported Net Loss for the year was (49.23 M) with profit before taxes, overhead, and interest of 4.3 M. Considering the 90-day investment horizon the next expected press release will be in about 7 days. Check out Historical Fundamental Analysis of ImageneBio to cross-verify your projections.ImageneBio Related Hype Analysis
Having access to credible news sources related to ImageneBio's direct competition is more important than ever and may enhance your ability to predict ImageneBio's future price movements. Getting to know how ImageneBio's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how ImageneBio may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| CNTB | Connect Biopharma Holdings | 0.10 | 8 per month | 3.89 | 0.12 | 11.89 | (6.42) | 36.83 | |
| IFRX | InflaRx NV | (0.03) | 7 per month | 0.00 | (0.07) | 7.92 | (9.17) | 43.11 | |
| KLRS | Kalaris Therapeutics | 0.88 | 9 per month | 4.26 | 0.18 | 15.58 | (8.21) | 32.70 | |
| STTK | Shattuck Labs | (0.09) | 9 per month | 2.77 | 0.25 | 7.29 | (4.55) | 27.07 | |
| CNTX | Context Therapeutics | 0.03 | 5 per month | 3.17 | 0.22 | 9.59 | (5.51) | 20.53 | |
| STRO | Sutro Biopharma | 0.54 | 11 per month | 5.30 | 0.11 | 11.76 | (7.78) | 27.28 | |
| ARTV | Artiva Biotherapeutics Common | 2.21 | 6 per month | 7.90 | 0.01 | 8.00 | (11.11) | 118.69 | |
| OVID | Ovid Therapeutics | (0.04) | 9 per month | 4.87 | 0.01 | 9.20 | (9.09) | 36.13 | |
| MGX | Metagenomi Common Stock | 0.02 | 8 per month | 0.00 | (0.20) | 6.02 | (8.57) | 19.55 | |
| QNCX | Quince Therapeutics | (0.02) | 17 per month | 4.25 | 0.15 | 11.88 | (7.90) | 42.36 |
Other Forecasting Options for ImageneBio
For every potential investor in ImageneBio, whether a beginner or expert, ImageneBio's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. ImageneBio Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in ImageneBio. Basic forecasting techniques help filter out the noise by identifying ImageneBio's price trends.ImageneBio Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with ImageneBio stock to make a market-neutral strategy. Peer analysis of ImageneBio could also be used in its relative valuation, which is a method of valuing ImageneBio by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
ImageneBio Market Strength Events
Market strength indicators help investors to evaluate how ImageneBio stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading ImageneBio shares will generate the highest return on investment. By undertsting and applying ImageneBio stock market strength indicators, traders can identify ImageneBio entry and exit signals to maximize returns.
ImageneBio Risk Indicators
The analysis of ImageneBio's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in ImageneBio's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting imagenebio stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 2.71 | |||
| Standard Deviation | 3.77 | |||
| Variance | 14.21 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for ImageneBio
The number of cover stories for ImageneBio depends on current market conditions and ImageneBio's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that ImageneBio is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about ImageneBio's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
ImageneBio Short Properties
ImageneBio's future price predictability will typically decrease when ImageneBio's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of ImageneBio often depends not only on the future outlook of the potential ImageneBio's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. ImageneBio's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 48.3 M | |
| Cash And Short Term Investments | 124.4 M |
Check out Historical Fundamental Analysis of ImageneBio to cross-verify your projections. For information on how to trade ImageneBio Stock refer to our How to Trade ImageneBio Stock guide.You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ImageneBio. Market participants price ImageneBio higher when confident in its future expansion prospects. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive ImageneBio assessment requires weighing all these inputs, though not all factors influence outcomes equally.
ImageneBio's market price often diverges from its book value, the accounting figure shown on ImageneBio's balance sheet. Smart investors calculate ImageneBio's intrinsic value—its true economic worth—which may differ significantly from both market price and book value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Since ImageneBio's trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
Please note, there is a significant difference between ImageneBio's value and its price as these two are different measures arrived at by different means. Investors typically determine if ImageneBio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ImageneBio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.